NCT00006203View on ClinicalTrials.gov

Naltrexone, Craving, and Drinking

PHASE4CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2005

Conditions

Alcoholism

Interventions

DRUG

Naltrexone 50 Mg

Daily 50 mg for 3 weeks

DRUG

Placebo

Daily doses of placebo for 3 weeks

Trial Locations (1)

02919

Center for Alcohol and Addiction Studies, Brown University, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Brown University

OTHER

NCT00006203 - Naltrexone, Craving, and Drinking | Biotech Hunter | Biotech Hunter